Press Releases

Calgary, Alberta--(Newsfile Corp. - May 8, 2024) - Saturn Oil & Gas Inc. (TSX: SOIL) (FSE: SMKA) (OTCQX: OILSF) ("Saturn" or the "Company") is pleased to announce that in connection with its previously announced bought-deal subscription receipt financing for aggregate gross proceeds of approximately $100 million (the "Offering"), the Company has filed a prospectus supplement (the "Prospectus Supplement") to its short form base shelf prospectus dated May 19, 2022, as... (continue reading...)

EBITDA reached BRL 628.9 million and free cash flow was BRL 367 million in the period

SÃO PAULO, May 8, 2024 /PRNewswire/ -- Minerva Foods (Minerva S.A. – B3: BEEF3 | OTC – Nasdaq International: MRVSY), the leading exporter of fresh beef and its derivatives in South America, which also operates in the processed meat segment, presents its financial results for the first quarter of 2024 (1Q24) to the market.

Free Cash Flow for 1Q24 totaled BRL 367 million. Over... (continue reading...)

PITTSBURGH--(BUSINESS WIRE)-- Smith Micro Software, Inc. (Nasdaq: SMSI) (“Smith Micro” or the “Company”) today reported financial results for its first quarter ended March 31, 2024.

“In the first quarter, we have made progress in several key areas that we believe position us for growth in the back half of this fiscal year,” said William W. Smith, Jr., president, chief executive officer, and chairman of the board of Smith Micro. “We are pleased to... (continue reading...)

LOS ANGELES, May 08, 2024 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of DoubleVerify Holdings, Inc. (“DoubleVerify” or “the Company”) (NYSE: DV) for violations of the securities laws.

The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. DoubleVerify... (continue reading...)

NYON, Switzerland--(BUSINESS WIRE)-- Edwards Lifesciences today announced the European launch of the SAPIEN 3 Ultra RESILIA valve, the only transcatheter aortic heart valve to incorporate the company’s breakthrough RESILIA tissue technology, designed to extend the valve’s durability.*

Edwards’ SAPIEN 3 Ultra RESILIA valve recently received CE Mark† for use in patients with heart valve disease due to native calcific aortic stenosis at all levels of surgical... (continue reading...)